Cancers, Vol. 16, Pages 1721: Textbook Neoadjuvant Outcome & mdash;Novel Composite Measure of Oncological Outcomes among Gastric Cancer Patients Undergoing Multimodal Treatment
Cancers, Vol. 16, Pages 1721: Textbook Neoadjuvant Outcome—Novel Composite Measure of Oncological Outcomes among Gastric Cancer Patients Undergoing Multimodal Treatment
Cancers doi: 10.3390/cancers16091721
Authors:
Zuzanna Pelc
Katarzyna Sędłak
Magdalena Leśniewska
Katarzyna Mielniczek
Katarzyna Chawrylak
Magdalena Skórzewska
Tomasz Ciszewski
Joanna Czechowska
Agata Kiszczyńska
Bas P. L. Wijnhoven
Johanna W. Van Van Sandick
Ines Gockel
Suzanne S. Gisbertz
Guillaume Piessen
Clarisse Eveno
Maria Bencivenga
Giovanni De Manzoni
Gian Luca Baiocchi
Paolo Morgagni
Riccardo Rosati
Uberto Fumagalli Romario
Andrew Davies
Yutaka Endo
Timothy M. Pawlik
Franco Roviello
Christiane Bruns
Wojciech P. Polkowski
Karol Rawicz-Pruszyński
The incidence of gastric cancer (GC) is expected to increase to 1.77 million cases by 2040. To improve treatment outcomes, GC patients are increasingly treated with neoadjuvant chemotherapy (NAC) prior to curative-intent resection. Although NAC enhances locoregional control and comprehensive patient care, survival rates remain poor, and further investigations should establish outcomes assessment of current clinical pathways. Individually assessed parameters have served as benchmarks for treatment quality in the past decades. The Outcome4Medicine Consensus Conference underscores the inadequacy of isolated metrics, leading to increased recognition and adoption of composite measures. One ...
Source: Cancers - Category: Cancer & Oncology Authors: Zuzanna Pelc Katarzyna S ędłak Magdalena Le śniewska Katarzyna Mielniczek Katarzyna Chawrylak Magdalena Sk órzewska Tomasz Ciszewski Joanna Czechowska Agata Kiszczy ńska Bas P. L. Wijnhoven Johanna W. Van Van Sandick Ines Gockel Suzanne S. Gisbertz G Tags: Review Source Type: research